CRP and cancer: Biomarkers such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), and cytokines have been suggested as measurable parameters of systemic inflammation and prognostic predictors in various cancers [3, 5, 6].